Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 527209, 13 pages
http://dx.doi.org/10.1155/2015/527209
Review Article

Natural Compounds Modulating Mitochondrial Functions

1Department of Surgery, Medicine, Dentistry and Morphological Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy
2Department of Life Sciences, University of Modena and Reggio Emilia, Via G. Campi 287, 41125 Modena, Italy

Received 11 May 2015; Accepted 11 June 2015

Academic Editor: Muriel Cuendet

Copyright © 2015 Lara Gibellini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. R. Duchen, “Mitochondria in health and disease: perspectives on a new mitochondrial biology,” Molecular Aspects of Medicine, vol. 25, no. 4, pp. 365–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Galluzzi, O. Kepp, and G. Kroemer, “Mitochondria: master regulators of danger signalling,” Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 780–788, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Galluzzi, O. Kepp, C. Trojel-Hansen, and G. Kroemer, “Mitochondrial control of cellular life, stress, and death,” Circulation Research, vol. 111, no. 9, pp. 1198–1207, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Galluzzi, E. Morselli, O. Kepp, I. Vitale, M. Pinti, and G. Kroemer, “Mitochondrial liaisons of p53,” Antioxidants & Redox Signaling, vol. 15, no. 6, pp. 1691–1714, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Rigoulet, E. D. Yoboue, and A. Devin, “Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling,” Antioxidants & Redox Signaling, vol. 14, no. 3, pp. 459–468, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. D. C. Wallace, “A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine,” Annual Review of Genetics, vol. 39, pp. 359–407, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Pinti, C. Mussini, and A. Cossarizza, “Mitochondrial DNA: a proinflammatory ‘enemy from within’ during HIV infection?” Cell Death and Disease, vol. 3, no. 5, article e307, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Sgarbi, P. Matarrese, M. Pinti et al., “Mitochondria hyperfusion and elevated autophagic activity are key mechanisms for cellular bioenergetic preservation in centenarians,” Aging, vol. 6, no. 4, pp. 296–310, 2014. View at Google Scholar · View at Scopus
  9. D. Monti, S. Salvioli, M. Capri et al., “Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians,” Mechanisms of Ageing and Development, vol. 121, no. 1–3, pp. 239–250, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Ferraresi, L. Troiano, M. Pinti et al., “Resistance of mtDNA-depleted cells to apoptosis,” Cytometry A, vol. 73, no. 6, pp. 528–537, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Gibellini, M. Pinti, M. Nasi et al., “Interfering with ROS metabolism in cancer cells: the potential role of quercetin,” Cancers, vol. 2, no. 2, pp. 1288–1311, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Giordano, M. Sebastiani, G. Plazzi et al., “Mitochondrial neurogastrointestinal encephalomyopathy: evidence of mitochondrial DNA depletion in the small intestine,” Gastroenterology, vol. 130, no. 3, pp. 893–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Kroemer, L. Galluzzi, and C. Brenner, “Mitochondrial membrane permeabilization in cell death,” Physiological Reviews, vol. 87, no. 1, pp. 99–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Fulda, L. Galluzzi, and G. Kroemer, “Targeting mitochondria for cancer therapy,” Nature Reviews Drug Discovery, vol. 9, no. 6, pp. 447–464, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Cossarizza, G. Kalashnikova, E. Grassilli et al., “Mitochondrial modifications during rat thymocyte apoptosis: a study at the single cell level,” Experimental Cell Research, vol. 214, no. 1, pp. 323–330, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Garcia Fernandez, L. Troiano, L. Moretti et al., “Early changes in intramitochondrial cardiolipin distribution during apoptosis,” Cell Growth and Differentiation, vol. 13, no. 9, pp. 449–455, 2002. View at Google Scholar · View at Scopus
  17. D. Monti, E. Grassilli, L. Troiano et al., “Senescence, immortalization, and apoptosis: an intriguing relationship,” Annals of the New York Academy of Sciences, vol. 673, pp. 70–82, 1992. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Pinti, P. Salomoni, and A. Cossarizza, “Anti-HIV drugs and the mitochondria,” Biochimica et Biophysica Acta: Bioenergetics, vol. 1757, no. 5-6, pp. 700–707, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. R. Gledhill, M. G. Montgomery, A. G. W. Leslie, and J. E. Walker, “Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 34, pp. 13632–13637, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J. R. Gledhill and J. E. Walker, “Inhibition sites in F1-ATPase from bovine heart mitochondria,” Biochemical Journal, vol. 386, part 3, pp. 591–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. J. L. Kipp and V. D. Ramirez, “Effect of estradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain,” Endocrine, vol. 15, no. 2, pp. 165–175, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sekiya, R. Hisasaka, A. Iwamoto-Kihara, M. Futai, and M. Nakanishi-Matsui, “A unique mechanism of curcumin inhibition on F1 ATPase,” Biochemical and Biophysical Research Communications, vol. 452, no. 4, pp. 940–944, 2014. View at Publisher · View at Google Scholar
  23. J. Zheng and V. D. Ramirez, “Inhibition of mitochondrial proton F0F1-ATPase/ATP synthase by polyphenolic phytochemicals,” British Journal of Pharmacology, vol. 130, no. 5, pp. 1115–1123, 2000. View at Publisher · View at Google Scholar · View at Scopus
  24. P. C. H. Hollman and M. B. Katan, “Dietary flavonoids: Intake, health effects and bioavailability,” Food and Chemical Toxicology, vol. 37, no. 9-10, pp. 937–942, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Gibellini, M. Pinti, M. Nasi et al., “Quercetin and cancer chemoprevention,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 591356, 15 pages, 2011. View at Publisher · View at Google Scholar
  26. B. B. Aggarwal, A. Kumar, and A. C. Bharti, “Anticancer potential of curcumin: preclinical and clinical studies,” Anticancer Research, vol. 23, no. 1, pp. 363–398, 2003. View at Google Scholar · View at Scopus
  27. V. Basile, E. Ferrari, S. Lazzari, S. Belluti, F. Pignedoli, and C. Imbriano, “Curcumin derivatives: molecular basis of their anti-cancer activity,” Biochemical Pharmacology, vol. 78, no. 10, pp. 1305–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. P. Sahu, S. Batra, and S. K. Srivastava, “Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells,” British Journal of Cancer, vol. 100, no. 9, pp. 1425–1433, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. S.-H. Jee, S.-C. Shen, C.-R. Tseng, H.-C. Chiu, and M.-L. Kuo, “Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells,” Journal of Investigative Dermatology, vol. 111, no. 4, pp. 656–661, 1998. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Kawamori, R. Lubet, V. E. Steele et al., “Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer,” Cancer Research, vol. 59, no. 3, pp. 597–601, 1999. View at Google Scholar · View at Scopus
  31. K. Mehta, P. Pantazis, T. McQueen, and B. B. Aggarwal, “Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines,” Anti-Cancer Drugs, vol. 8, no. 5, pp. 470–481, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Hayun, E. Okun, A. Berrebi et al., “Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells,” Leukemia and Lymphoma, vol. 50, no. 4, pp. 625–632, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Purkayastha, A. Berliner, S. S. Fernando et al., “Curcumin blocks brain tumor formation,” Brain Research, vol. 1266, pp. 130–138, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Sekiya, E. Chiba, M. Satoh et al., “Strong inhibitory effects of curcumin and its demethoxy analog on Escherichia coli ATP synthase F1 sector,” International Journal of Biological Macromolecules, vol. 70, pp. 241–245, 2014. View at Publisher · View at Google Scholar
  35. M. Sekiya, R. K. Nakamoto, M. Nakanishi-Matsui, and M. Futai, “Binding of phytopolyphenol piceatannol disrupts β/γ subunit interactions and rate-limiting step of steady-state rotational catalysis in Escherichia coli F1-ATpase,” The Journal of Biological Chemistry, vol. 287, no. 27, pp. 22771–22780, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Fiorani, A. Guidarelli, M. Blasa et al., “Mitochondria accumulate large amounts of quercetin: prevention of mitochondrial damage and release upon oxidation of the extramitochondrial fraction of the flavonoid,” Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 397–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. D. R. Lang and E. Racker, “Effects of quercetin and F1 inhibitor on mitochondrial ATPase and energy-linked reactions in submitochondrial particles,” Biochimica et Biophysica Acta, vol. 333, no. 2, pp. 180–186, 1974. View at Publisher · View at Google Scholar · View at Scopus
  38. R. Ortega and N. García, “The flavonoid quercetin induces changes in mitochondrial permeability by inhibiting adenine nucleotide translocase,” Journal of Bioenergetics and Biomembranes, vol. 41, no. 1, pp. 41–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. D. J. Dorta, A. A. Pigoso, F. E. Mingatto et al., “The interaction of flavonoids with mitochondria: effects on energetic processes,” Chemico-Biological Interactions, vol. 152, no. 2-3, pp. 67–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Trumbeckaite, J. Bernatoniene, D. Majiene, V. Jakštas, A. Savickas, and A. Toleikis, “The effect of flavonoids on rat heart mitochondrial function,” Biomedicine and Pharmacotherapy, vol. 60, no. 5, pp. 245–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Lagouge, C. Argmann, Z. Gerhart-Hines et al., “Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α,” Cell, vol. 127, no. 6, pp. 1109–1122, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Murase, S. Haramizu, N. Ota, and T. Hase, “Suppression of the aging-associated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice,” Biogerontology, vol. 10, no. 4, pp. 423–434, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. N. Hart, L. Sarga, Z. Csende et al., “Resveratrol attenuates exercise-induced adaptive responses in rats selectively bred for low running performance,” Dose-Response, vol. 12, no. 1, pp. 57–71, 2014. View at Publisher · View at Google Scholar
  44. N. Hart, L. Sarga, Z. Csende et al., “Resveratrol enhances exercise training responses in rats selectively bred for high running performance,” Food and Chemical Toxicology, vol. 61, pp. 53–59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. H. W. Lim, H. Y. Lim, and K. P. Wong, “Uncoupling of oxidative phosphorylation by curcumin: implication of its cellular mechanism of action,” Biochemical and Biophysical Research Communications, vol. 389, no. 1, pp. 187–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. B. Chance and G. Hollunger, “The interaction of energy and electron transfer reactions in mitochondria. I. General properties and nature of the products of succinate-linked reduction of pyridine nucleotide,” The Journal of Biological Chemistry, vol. 236, pp. 1534–1543, 1961. View at Google Scholar · View at Scopus
  47. E. B. Tahara, F. D. T. Navarete, and A. J. Kowaltowski, “Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation,” Free Radical Biology and Medicine, vol. 46, no. 9, pp. 1283–1297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. C. G. M. Heijnen, G. R. M. M. Haenen, F. A. A. van Acker, W. J. F. van der Vijgh, and A. Bast, “Flavonoids as peroxynitrite scavengers: the role of the hydroxyl groups,” Toxicology in Vitro, vol. 15, no. 1, pp. 3–6, 2001. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Metodiewa, A. K. Jaiswal, N. Cenas, E. Dickancaité, and J. Segura-Aguilar, “Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product,” Free Radical Biology and Medicine, vol. 26, no. 1-2, pp. 107–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Yoshino, M. Haneda, M. Naruse, and K. Murakami, “Prooxidant activity of flavonoids: copper-dependent strand breaks and the formation of 8-hydroxy-2′-deoxyguanosine in DNA,” Molecular Genetics and Metabolism, vol. 68, no. 4, pp. 468–472, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. A. M. Ramos and P. Aller, “Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines,” Biochemical Pharmacology, vol. 75, no. 10, pp. 1912–1923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. R. Ferraresi, L. Troiano, E. Roat et al., “Essential requirement of reduced glutathione (GSH) for the anti-oxidant effect of the flavonoid quercetin,” Free Radical Research, vol. 39, no. 11, pp. 1249–1258, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. R. Kachadourian and B. J. Day, “Flavonoid-induced glutathione depletion: potential implications for cancer treatment,” Free Radical Biology and Medicine, vol. 41, no. 1, pp. 65–76, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. A. W. Boots, N. Kubben, G. R. M. M. Haenen, and A. Bast, “Oxidized quercetin reacts with thiols rather than with ascorbate: implication for quercetin supplementation,” Biochemical and Biophysical Research Communications, vol. 308, no. 3, pp. 560–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. C. Sahu and G. C. Gray, “Pro-oxidant activity of flavanoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei,” Cancer Letters, vol. 104, no. 2, pp. 193–196, 1996. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Lu, L. V. Papp, J. Fang, S. Rodriguez-Nieto, B. Zhivotovsky, and A. Holmgren, “Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity,” Cancer Research, vol. 66, no. 8, pp. 4410–4418, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. J. D. Hayes and A. T. Dinkova-Kostova, “The Nrf2 regulatory network provides an interface between redox and intermediary metabolism,” Trends in Biochemical Sciences, vol. 39, no. 4, pp. 199–218, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Itoh, P. Ye, T. Matsumiya, K. Tanji, and T. Ozaki, “Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria,” Journal of Clinical Biochemistry and Nutrition, vol. 56, no. 2, pp. 91–97, 2015. View at Publisher · View at Google Scholar
  59. A. B. Granado-Serrano, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, “Quercetin modulates Nrf2 and glutathione-related defenses in HepG2 cells: involvement of p38,” Chemico-Biological Interactions, vol. 195, no. 2, pp. 154–164, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Tanigawa, M. Fujii, and D.-X. Hou, “Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin,” Free Radical Biology and Medicine, vol. 42, no. 11, pp. 1690–1703, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. Sanhueza, J. Valdes, R. Campos, A. Garrido, and A. Valenzuela, “Changes in the xanthine dehydrogenase/xanthine oxidase ratio in the rat kidney subjected to ischemia-reperfusion stress: preventive effect of some flavonoids,” Research Communications in Chemical Pathology and Pharmacology, vol. 78, no. 2, pp. 211–218, 1992. View at Google Scholar · View at Scopus
  62. O. Çevik, S. Çadrc, T. E. Şener et al., “Quercetin treatment against ischemia/reperfusion injury in rat corpus cavernosum tissue: a role on apoptosis and oxidative stress,” Free Radical Research, vol. 47, no. 9, pp. 683–691, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. A. Ghosh, S. Sarkar, A. K. Mandal, and N. Das, “Neuroprotective role of nanoencapsulated quercetin in combating ischemia-reperfusion induced neuronal damage in young and aged rats,” PLoS ONE, vol. 8, no. 4, Article ID e57735, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Lorenz, S. Roychowdhury, M. Engelmann, G. Wolf, and T. F. W. Horn, “Oxyresveratrol and resveratrol are potent antioxidants and free radical scavengers: effect on nitrosative and oxidative stress derived from microglial cells,” Nitric Oxide: Biology and Chemistry, vol. 9, no. 2, pp. 64–76, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. P. Guha, A. Dey, M. V. Dhyani et al., “Calpain and caspase orchestrated death signal to accomplish apoptosis induced by resveratrol and its novel analog hydroxstilbene-1 in cancer cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 2, pp. 381–394, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. S. S. Leonard, C. Xia, B.-H. Jiang et al., “Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses,” Biochemical and Biophysical Research Communications, vol. 309, no. 4, pp. 1017–1026, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. L.-M. Hung, M.-J. Su, W.-K. Chu, C.-W. Chiao, W.-F. Chan, and J.-K. Chen, “The protective effect of resveratrols on ischaemia-reperfusion injuries of rat hearts is correlated with antioxidant efficacy,” British Journal of Pharmacology, vol. 135, no. 7, pp. 1627–1633, 2002. View at Publisher · View at Google Scholar · View at Scopus
  68. Y.-G. Li, W. Zhu, J.-P. Tao et al., “Resveratrol protects cardiomyocytes from oxidative stress through SIRT1 and mitochondrial biogenesis signaling pathways,” Biochemical and Biophysical Research Communications, vol. 438, no. 2, pp. 270–276, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. M. Shen, R.-X. Wu, L. Zhao et al., “Resveratrol attenuates ischemia/reperfusion injury in neonatal cardiomyocytes and its underlying mechanism,” PLoS ONE, vol. 7, no. 12, Article ID e51223, 2012. View at Publisher · View at Google Scholar · View at Scopus
  70. H. Zheng, H. Guo, Y. Hong, F. Zheng, and J. Wang, “The effects of age and resveratrol on the hypoxic preconditioning protection against hypoxia-reperfusion injury: studies in rat hearts and human cardiomyocytes,” European Journal of Cardio-Thoracic Surgery, 2015. View at Publisher · View at Google Scholar
  71. E. Hirzel, P. W. Lindinger, S. Maseneni et al., “Differential modulation of ROS signals and other mitochondrial parameters by the antioxidants MitoQ, resveratrol and curcumin in human adipocytes,” Journal of Receptors and Signal Transduction, vol. 33, no. 5, pp. 304–312, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. B. Bellaver, D. G. Souza, D. O. Souza, and A. Quincozes-Santos, “Resveratrol increases antioxidant defenses and decreases proinflammatory cytokines in hippocampal astrocyte cultures from newborn, adult and aged Wistar rats,” Toxicology in Vitro, vol. 28, no. 4, pp. 479–484, 2014. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Soeur, J. Eilstein, G. Léreaux, C. Jones, and L. Marrot, “Skin resistance to oxidative stress induced by resveratrol: from Nrf2 activation to GSH biosynthesis,” Free Radical Biology and Medicine, vol. 78, pp. 213–223, 2015. View at Publisher · View at Google Scholar
  74. X. Zhou, M. Chen, X. Zeng et al., “Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells,” Cell Death and Disease, vol. 5, no. 12, Article ID e1576, 2014. View at Publisher · View at Google Scholar
  75. Z. Ungvari, Z. Bagi, A. Feher et al., “Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 299, no. 1, pp. H18–H24, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. Z. Ungvari, Z. Orosz, A. Rivera et al., “Resveratrol increases vascular oxidative stress resistance,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2417–H2424, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. Z. Ungvari, N. Labinskyy, P. Mukhopadhyay et al., “Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 297, no. 5, pp. H1876–H1881, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. W.-H. Chan, H.-J. Wu, and Y.-D. Hsuuw, “Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells,” Annals of the New York Academy of Sciences, vol. 1042, pp. 372–378, 2005. View at Publisher · View at Google Scholar · View at Scopus
  79. J. M. Woo, D.-Y. Shin, S. J. Lee et al., “Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen,” Molecular Vision, vol. 18, pp. 901–908, 2012. View at Google Scholar · View at Scopus
  80. H. Jiang, X. Tian, Y. Guo, W. Duan, H. Bu, and C. Li, “Activation of nuclear factor erythroid 2-related factor 2 cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity,” Biological and Pharmaceutical Bulletin, vol. 34, no. 8, pp. 1194–1197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  81. P. Manikandan, M. Sumitra, S. Aishwarya, B. M. Manohar, B. Lokanadam, and R. Puvanakrishnan, “Curcumin modulates free radical quenching in myocardial ischaemia in rats,” The International Journal of Biochemistry & Cell Biology, vol. 36, no. 10, pp. 1967–1980, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. T. Ak and I. Gülçin, “Antioxidant and radical scavenging properties of curcumin,” Chemico-Biological Interactions, vol. 174, no. 1, pp. 27–37, 2008. View at Publisher · View at Google Scholar · View at Scopus
  83. S. Derochette, T. Franck, A. Mouithys-Mickalad et al., “Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils,” Chemico-Biological Interactions, vol. 206, no. 2, pp. 186–193, 2013. View at Publisher · View at Google Scholar · View at Scopus
  84. A. Barzegar and A. A. Moosavi-Movahedi, “Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin,” PLoS ONE, vol. 6, no. 10, Article ID e26012, 2011. View at Publisher · View at Google Scholar · View at Scopus
  85. J. E. Kim, A. R. Kim, H. Y. Chung, S. Y. Han, B. S. Kim, and J. S. Choi, “In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa,” Phytotherapy Research, vol. 17, no. 5, pp. 481–484, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Sumanont, Y. Murakami, M. Tohda, O. Vajragupta, K. Matsumoto, and H. Watanabe, “Evaluation of the nitric oxide radical scavenging activity of manganese complexes of curcumin and its derivative,” Biological and Pharmaceutical Bulletin, vol. 27, no. 2, pp. 170–173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  87. H. D. Panchal, K. Vranizan, C. Y. Lee, J. Ho, J. Ngai, and P. S. Timiras, “Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets,” Neurochemical Research, vol. 33, no. 9, pp. 1701–1710, 2008. View at Publisher · View at Google Scholar · View at Scopus
  88. G. S. Jeong, G. S. Oh, H. O. Pae et al., “Comparative effects of curcuminoids on endothelial heme oxygenase-1 expression: ortho-methoxy groups are essential to enhance heme oxygenase activity and protection,” Experimental & Molecular Medicine, vol. 38, no. 4, pp. 393–400, 2006. View at Google Scholar
  89. L. M. Reyes-Fermín, S. González-Reyes, N. G. Tarco-Álvarez, M. Hernández-Nava, M. Orozco-Ibarra, and J. Pedraza-Chaverri, “Neuroprotective effect of α-mangostin and curcumin against iodoacetate-induced cell death,” Nutritional Neuroscience, vol. 15, no. 5, pp. 34–41, 2012. View at Publisher · View at Google Scholar · View at Scopus
  90. L. P. Yarru, R. S. Settivari, N. K. S. Gowda, E. Antoniou, D. R. Ledoux, and G. E. Rottinghaus, “Effects of turmeric (Curcuma longa) on the expression of hepatic genes associated with biotransformation, antioxidant, and immune systems in broiler chicks fed aflatoxin,” Poultry Science, vol. 88, no. 12, pp. 2620–2627, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. E. Balogun, R. Foresti, C. J. Green, and R. Motterlini, “Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells,” Biochemical and Biophysical Research Communications, vol. 308, no. 4, pp. 950–955, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. E. Balogun, M. Hoque, P. Gong et al., “Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element,” Biochemical Journal, vol. 371, no. 3, pp. 887–895, 2003. View at Publisher · View at Google Scholar · View at Scopus
  93. S. Gao, X. Duan, X. Wang et al., “Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion,” Food and Chemical Toxicology, vol. 59, pp. 739–747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Garg, S. Gupta, and G. B. Maru, “Dietary curcumin modulates transcriptional regulators of phase I and phase II enzymes in benzo[α]pyrene-treated mice: mechanism of its anti-initiating action,” Carcinogenesis, vol. 29, no. 5, pp. 1022–1032, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. A. González-Salazar, E. Molina-Jijón, F. Correa et al., “Curcumin protects from cardiac reperfusion damage by attenuation of oxidant stress and mitochondrial dysfunction,” Cardiovascular Toxicology, vol. 11, no. 4, pp. 357–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  96. F. Correa, M. Buelna-Chontal, S. Hernández-Reséndiz et al., “Curcumin maintains cardiac and mitochondrial function in chronic kidney disease,” Free Radical Biology and Medicine, vol. 61, pp. 119–129, 2013. View at Publisher · View at Google Scholar · View at Scopus
  97. E. Molina-Jijón, E. Tapia, C. Zazueta et al., “Curcumin prevents Cr(VI)-induced renal oxidant damage by a mitochondrial pathway,” Free Radical Biology and Medicine, vol. 51, no. 8, pp. 1543–1557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  98. A. K. Chandra, A. Chatterjee, R. Ghosh, and M. Sarkar, “Effect of curcumin on chromium-induced oxidative damage in male reproductive system,” Environmental Toxicology and Pharmacology, vol. 24, no. 2, pp. 160–166, 2007. View at Publisher · View at Google Scholar · View at Scopus
  99. W. R. García-Niño, E. Tapia, C. Zazueta et al., “Curcumin pretreatment prevents potassium dichromate-induced hepatotoxicity, oxidative stress, decreased respiratory complex I activity, and membrane permeability transition pore opening,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 424692, 19 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. N. Sivalingam, J. Basivireddy, K. A. Balasubramanian, and M. Jacob, “Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction,” Archives of Toxicology, vol. 82, no. 7, pp. 471–481, 2008. View at Publisher · View at Google Scholar · View at Scopus
  101. S. Fulda, “Modulation of apoptosis by natural products for cancer therapy,” Planta Medica, vol. 76, no. 11, pp. 1075–1079, 2010. View at Publisher · View at Google Scholar · View at Scopus
  102. N. Rayamajhi, S.-K. Kim, H. Go et al., “Quercetin induces mitochondrial biogenesis through activation of HO-1 in HepG2 cells,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 154279, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. D. C. Nieman, A. S. Williams, R. A. Shanely et al., “Quercetin's influence on exercise performance and muscle mitochondrial biogenesis,” Medicine and Science in Sports and Exercise, vol. 42, no. 2, pp. 338–345, 2010. View at Publisher · View at Google Scholar · View at Scopus
  104. S. M. Kwon, H. G. Park, J. K. Jun, and W. L. Lee, “Exercise, but not quercetin, ameliorates inflammation, mitochondrial biogenesis, and lipid metabolism in skeletal muscle after strenuous exercise by high-fat diet mice,” The Journal of Exercise Nutrition and Biochemistry, vol. 6, no. 1, pp. 51–60, 1975. View at Publisher · View at Google Scholar
  105. R. A. Casuso, E. J. Martínez-López, F. Hita-Contreras et al., “The combination of oral quercetin supplementation and exercise prevents brain mitochondrial biogenesis,” Genes & Nutrition, vol. 9, no. 5, p. 420, 2014. View at Publisher · View at Google Scholar
  106. T.-J. Lee, O. H. Kim, Y. H. Kim et al., “Quercetin arrests G2/M phase and induces caspase-dependent cell death in U937 cells,” Cancer Letters, vol. 240, no. 2, pp. 234–242, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. J.-H. Yang, T.-C. Hsia, H.-M. Kuo et al., “Inhibition of lung cancer cell growth by quercetin glucuronides via G2/M arrest and induction of apoptosis,” Drug Metabolism and Disposition, vol. 34, no. 2, pp. 296–304, 2006. View at Publisher · View at Google Scholar · View at Scopus
  108. S.-Y. Chien, Y.-C. Wu, J.-G. Chung et al., “Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells,” Human and Experimental Toxicology, vol. 28, no. 8, pp. 493–503, 2009. View at Publisher · View at Google Scholar · View at Scopus
  109. A. B. Granado-Serrano, M. A. Martín, L. Bravo, L. Goya, and S. Ramos, “Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2),” Journal of Nutrition, vol. 136, no. 11, pp. 2715–2721, 2006. View at Google Scholar · View at Scopus
  110. J. Tan, B. Wang, and L. Zhu, “Regulation of survivin and Bcl-2 in HepG2 cell apoptosis induced by quercetin,” Chemistry and Biodiversity, vol. 6, no. 7, pp. 1101–1110, 2009. View at Publisher · View at Google Scholar · View at Scopus
  111. L. Troiano, R. Ferraresi, E. Lugli et al., “Multiparametric analysis of cells with different mitochondrial membrane potential during apoptosis by polychromatic flow cytometry,” Nature Protocols, vol. 2, no. 11, pp. 2719–2727, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. E. Lugli, R. Ferraresi, E. Roat et al., “Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells,” Leukemia Research, vol. 33, no. 1, pp. 140–150, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. J.-H. Jeong, J. Y. An, Y. T. Kwon, J. G. Rhee, and Y. J. Lee, “Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression,” Journal of Cellular Biochemistry, vol. 106, no. 1, pp. 73–82, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. Y.-K. Lee, J.-T. Hwang, D. Y. Kwon, Y.-J. Surh, and O. J. Park, “Induction of apoptosis by quercetin is mediated through AMPKα1/ASK1/p38 pathway,” Cancer Letters, vol. 292, no. 2, pp. 228–236, 2010. View at Publisher · View at Google Scholar · View at Scopus
  115. A. Matsuzawa and H. Ichijo, “Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling,” Biochimica et Biophysica Acta—General Subjects, vol. 1780, no. 11, pp. 1325–1336, 2008. View at Publisher · View at Google Scholar · View at Scopus
  116. Y.-K. Lee, Y. P. Song, Y.-M. Kim, S. L. Won, and J. P. Ock, “AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin,” Experimental and Molecular Medicine, vol. 41, no. 3, pp. 201–207, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. G. T. Kim, S. H. Lee, and Y. M. Kim, “Quercetin regulates sestrin 2-AMPK-mTOR signaling pathway and induces apoptosis via increased intracellular ROS in HCT116 colon cancer cells,” Journal of Cancer Prevention, vol. 18, no. 3, pp. 264–270, 2013. View at Publisher · View at Google Scholar
  118. J.-H. Um, S.-J. Park, H. Kang et al., “AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol,” Diabetes, vol. 59, no. 3, pp. 554–563, 2010. View at Publisher · View at Google Scholar · View at Scopus
  119. K. J. Menzies, K. Singh, A. Saleem, and D. A. Hood, “Sirtuin 1-mediated effects of exercise and resveratrol on mitochondrial biogenesis,” The Journal of Biological Chemistry, vol. 288, no. 10, pp. 6968–6979, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Chung, H. Yao, S. Caito, J.-W. Hwang, G. Arunachalam, and I. Rahman, “Regulation of SIRT1 in cellular functions: role of polyphenols,” Archives of Biochemistry and Biophysics, vol. 501, no. 1, pp. 79–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  121. K. T. Howitz, K. J. Bitterman, H. Y. Cohen et al., “Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan,” Nature, vol. 425, no. 6954, pp. 191–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Pacholec, J. E. Bleasdale, B. Chrunyk et al., “SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1,” Journal of Biological Chemistry, vol. 285, no. 11, pp. 8340–8351, 2010. View at Publisher · View at Google Scholar · View at Scopus
  123. D. Beher, J. Wu, S. Cumine et al., “Resveratrol is not a direct activator of SIRT1 enzyme activity,” Chemical Biology and Drug Design, vol. 74, no. 6, pp. 619–624, 2009. View at Publisher · View at Google Scholar · View at Scopus
  124. K. Higashida, S. H. Kim, S. R. Jung, M. Asaka, J. O. Holloszy, and D.-H. Han, “Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation,” PLoS Biology, vol. 11, no. 7, Article ID e1001603, 2013. View at Publisher · View at Google Scholar · View at Scopus
  125. D. Sareen, S. R. Darjatmoko, D. M. Albert, and A. S. Polans, “Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer,” Molecular Pharmacology, vol. 72, no. 6, pp. 1466–1475, 2007. View at Publisher · View at Google Scholar · View at Scopus
  126. X. Ma, X. Tian, X. Huang, F. Yan, and D. Qiao, “Resveratrol-induced mitochondrial dysfunction and apoptosis are associated with Ca2+ and mCICR-mediated MPT activation in HepG2 cells,” Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 99–109, 2007. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Fulda and K.-M. Debatin, “Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol,” Cancer Research, vol. 64, no. 1, pp. 337–346, 2004. View at Publisher · View at Google Scholar · View at Scopus
  128. A. R. Jazirehi and B. Bonavida, “Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis,” Molecular Cancer Therapeutics, vol. 3, no. 1, pp. 71–84, 2004. View at Google Scholar · View at Scopus
  129. A. Bhardwaj, G. Sethi, S. Vadhan-Raj et al., “Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells,” Blood, vol. 109, no. 6, pp. 2293–2302, 2007. View at Google Scholar
  130. J.-W. Park, Y.-J. Choi, S.-I. Suh et al., “Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity,” Carcinogenesis, vol. 22, no. 10, pp. 1633–1639, 2001. View at Publisher · View at Google Scholar · View at Scopus
  131. L. Tessitore, A. Davit, I. Sarotto, and G. Caderni, “Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression,” Carcinogenesis, vol. 21, no. 8, pp. 1619–1622, 2000. View at Publisher · View at Google Scholar · View at Scopus
  132. M. Mahyar-Roemer, A. Katsen, P. Mestres, and K. Roemer, “Resveratrol induces colon tumor cell apoptosis independently of p53 and precede by epithelial differentiation, mitochondrial proliferation and membrane potential collapse,” International Journal of Cancer, vol. 94, no. 5, pp. 615–622, 2001. View at Publisher · View at Google Scholar · View at Scopus
  133. M. Mahyar-Roemer, H. Köhler, and K. Roemer, “Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells,” BMC Cancer, vol. 2, no. 1, article 27, 2002. View at Google Scholar · View at Scopus
  134. J.-J. Kuo, H.-H. Chang, T.-H. Tsai, and T.-Y. Lee, “Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis,” International Journal of Molecular Medicine, vol. 30, no. 3, pp. 643–649, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. J. Cao, L. Jia, H.-M. Zhou, Y. Liu, and L.-F. Zhong, “Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells,” Toxicological Sciences, vol. 91, no. 2, pp. 476–483, 2006. View at Publisher · View at Google Scholar · View at Scopus
  136. Y. Kim, H. D. Kim, and J. Kim, “Cytoplasmic ribosomal protein S3 (rpS3) plays a pivotal role in mitochondrial DNA damage surveillance,” Biochimica et Biophysica Acta, vol. 1833, no. 12, pp. 2943–2952, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. J. Cao, Y. Liu, L. Jia et al., “Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells,” Free Radical Biology and Medicine, vol. 43, no. 6, pp. 968–975, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. L. Liu, W. Zhang, L. Wang et al., “Curcumin prevents cerebral ischemia reperfusion injury via increase of mitochondrial biogenesis,” Neurochemical Research, vol. 39, no. 7, pp. 1322–1331, 2014. View at Publisher · View at Google Scholar · View at Scopus
  139. L. Li, B. B. Aggarwal, S. Shishodia, J. Abbruzzese, and R. Kurzrock, “Nuclear factor-κB and IκB are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis,” Cancer, vol. 101, no. 10, pp. 2351–2362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  140. J. L. Watson, R. Hill, P. B. Yaffe et al., “Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells,” Cancer Letters, vol. 297, no. 1, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  141. D. Morin, S. Barthélémy, R. Zini, S. Labidalle, and J.-P. Tillement, “Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation,” FEBS Letters, vol. 495, no. 1-2, pp. 131–136, 2001. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Karmakar, N. L. Banik, S. J. Patel, and S. K. Ray, “Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells,” Neuroscience Letters, vol. 407, no. 1, pp. 53–58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  143. R. Gogada, M. Amadori, H. Zhang et al., “Curcumin induces Apaf-1-dependent, p21-mediated caspase activation and apoptosis,” Cell Cycle, vol. 10, no. 23, pp. 4128–4137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina, “Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway,” Journal of Biological Chemistry, vol. 279, no. 12, pp. 11680–11685, 2004. View at Publisher · View at Google Scholar · View at Scopus
  145. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, “Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction,” FEBS Letters, vol. 512, no. 1–3, pp. 334–340, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. R. Rashmi, S. Kumar, and D. Karunagaran, “Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL,” Carcinogenesis, vol. 26, no. 4, pp. 713–723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  147. S. Shankar and R. K. Srivastava, “Bax and Bak genes are essential for maximum apoptotic response by curcumin, a polyphenolic compound and cancer chemopreventive agent derived from turmeric, Curcuma longa,” Carcinogenesis, vol. 28, no. 6, pp. 1277–1286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, “Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis,” Blood, vol. 101, no. 3, pp. 1053–1062, 2003. View at Publisher · View at Google Scholar · View at Scopus
  149. R. M. Anson and V. A. Bohr, “Mitochondria, oxidative DNA damage, and aging,” Journal of the American Aging Association, vol. 23, no. 4, pp. 199–218, 2000. View at Google Scholar · View at Scopus
  150. S. Judge, Y. M. Jang, A. Smith, T. Hagen, and C. Leeuwenburgh, “Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging,” The FASEB Journal, vol. 19, no. 3, pp. 419–421, 2005. View at Publisher · View at Google Scholar · View at Scopus
  151. N. J. Linford, S. E. Schriner, and P. S. Rabinovitch, “Oxidative damage and aging: spotlight on mitochondria,” Cancer Research, vol. 66, no. 5, pp. 2497–2499, 2006. View at Publisher · View at Google Scholar · View at Scopus
  152. M. López-Torres, R. Gredilla, A. Sanz, and G. Barja, “Influence of aging and long-term caloric restriction on oxygen radical generation and oxidative DNA damage in rat liver mitochondria,” Free Radical Biology and Medicine, vol. 32, no. 9, pp. 882–889, 2002. View at Publisher · View at Google Scholar · View at Scopus
  153. Z. Ungvari, N. Labinskyy, S. Gupte, P. N. Chander, J. G. Edwards, and A. Csiszar, “Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 294, no. 5, pp. H2121–H2128, 2008. View at Publisher · View at Google Scholar · View at Scopus
  154. J. J. Smith, R. D. Kenney, D. J. Gagne et al., “Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo,” BMC Systems Biology, vol. 3, article 31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  155. M. G. Novelle, D. Wahl, C. Diéguez, M. Bernier, and R. de Cabo, “Resveratrol supplementation: where are we now and where should we go?” Ageing Research Reviews, vol. 21, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  156. I. Sadowska-Bartosz and G. Bartosz, “Effect of antioxidants supplementation on aging and longevity,” BioMed Research International, vol. 2014, Article ID 404680, 17 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  157. J. Marchal, F. Pifferi, and F. Aujard, “Resveratrol in mammals: effects on aging biomarkers, age-related diseases, and life span,” Annals of the New York Academy of Sciences, vol. 1290, no. 1, pp. 67–73, 2013. View at Publisher · View at Google Scholar · View at Scopus